Sugimachi K, Okudaira Y
Gan No Rinsho. 1986 Aug;32(10):1153-6.
The recent amazing improvements in surgery for esophageal carcinoma which have been due largely to several factors such as pre- and postoperative management, surgical techniques, etc., have reduced the operative mortality. However, long term survival rates are not yet satisfactory. As more than 95% of patients with esophageal carcinoma are advanced carcinoma, multidisciplinary treatment is necessary. We have devised preoperative hyperthermo-chemo-radiotherapy, intraoperative local adjuvant chemotherapy, and postoperative long term cancer chemotherapy. Long term results of these combined therapy suggested the effectiveness of multidisciplinary treatment.
近期食管癌手术取得的惊人进展很大程度上归功于术前和术后管理、手术技术等多种因素,这降低了手术死亡率。然而,长期生存率仍不尽人意。由于超过95%的食管癌患者为进展期癌,多学科治疗很有必要。我们设计了术前热化疗放疗、术中局部辅助化疗以及术后长期癌症化疗。这些联合治疗的长期结果表明了多学科治疗的有效性。